Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2014

Nov 3, 2014

284_dirs_2014-11-03_abf240cb-82b1-4ef6-86c4-6a1717f97f51.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-11-02

Reporting Person: DeLuca Richard R. (EVP&Pres, Merck Animal Health)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-11-02 Common Stock M 4387.0000 $0.0000 Acquired 4387.0000 Direct
2014-11-02 Common Stock F 1635.0000 $57.9400 Disposed 2752.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-11-02 Restricted Stock Unit $ M 4387.0000 Disposed 2014-11-02 Common Stock (4387.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock - 401(k) Plan 596.1440 Indirect

Footnotes

F1: Includes shares acquired and dividends earned through October 7, 2014, in the Merck U.S. Savings Plan, a 401(k) plan.

F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.